Maria B. Brix
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria B. Brix has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Allison Rodgers
Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA
1 shared publication - Betty Pham
Division of Neonatology, Department of Pediatrics, University of California, San Diego, USA
1 shared publication - David J. McCulley
Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA 92093, USA
1 shared publication - Diana Marcela Tabima
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin
1 shared publication - Giangela M. Stokes
University of California
1 shared publication Gracia Sandok
Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53705, USA
1 shared publication
Latest Publications
- 31 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (732) , eadc8930
Rescuing lung development through embryonic inhibition of histone acetylation
A major barrier to the impact of genomic diagnosis in patients with congenital malformations is the lack of understanding regarding how sequence variants contribute to disease pathogenesis and whether this information could be used to generate patient-specific therapies. Congenital diaphragmatic hernia (CDH) is among the most common and severe of all structural malformations; however, its underlying mechanisms are unclear. We identified loss-of-function sequence variants in the epigenomic regulator geneSIN3Ain two patients with complex CDH. Tissue-specific deletion ofSin3ain mice resulted in defects in diaphragm development, lung hypoplasia, and pulmonary hypertension, the cardinal features of CDH and major causes of CDH-associated mortality. Loss of SIN3A in the lung mesenchyme resulted in reduced cellular differentiation, impaired cell proliferation, and increased DNA damage. Treatment of embryonicSin3amutant mice with anacardic acid, an inhibitor of histone acetyltransferase, reduced DNA damage, increased cell proliferation and differentiation, improved lung and pulmonary vascular development, and reduced pulmonary hypertension. These findings demonstrate that restoring the balance of histone acetylation can improve lung development in theSin3amouse model of CDH.
- 31 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (732) , eadc8930
Rescuing lung development through embryonic inhibition of histone acetylation
A major barrier to the impact of genomic diagnosis in patients with congenital malformations is the lack of understanding regarding how sequence variants contribute to disease pathogenesis and whether this information could be used to generate patient-specific therapies. Congenital diaphragmatic hernia (CDH) is among the most common and severe of all structural malformations; however, its underlying mechanisms are unclear. We identified loss-of-function sequence variants in the epigenomic regulator geneSIN3Ain two patients with complex CDH. Tissue-specific deletion ofSin3ain mice resulted in defects in diaphragm development, lung hypoplasia, and pulmonary hypertension, the cardinal features of CDH and major causes of CDH-associated mortality. Loss of SIN3A in the lung mesenchyme resulted in reduced cellular differentiation, impaired cell proliferation, and increased DNA damage. Treatment of embryonicSin3amutant mice with anacardic acid, an inhibitor of histone acetyltransferase, reduced DNA damage, increased cell proliferation and differentiation, improved lung and pulmonary vascular development, and reduced pulmonary hypertension. These findings demonstrate that restoring the balance of histone acetylation can improve lung development in theSin3amouse model of CDH.